针对晚期非小细胞肺癌的新兴向治疗方法
Fred R Hirsch1, Kenichi Suda2, Jacinta Wiens3
1Department of Medicine, Division of Medical Oncology and Department of Pathology, University of Colorado Cancer Center, Aurora, CO, USA; International Association for the Study of Lung Cancer, Aurora, CO, USA.
通过向特定突变和免疫路径, 针对性疗法正在彻底改变肺癌的治疗. 目前正在进行的研究重点是开发新药,克服耐药性,以改善晚期非小细胞肺癌患者的治疗结果.
科学领域:
- 癌症学
- 药理学
- 分子生物学
背景情况:
- 针对性疗法代表了肺癌管理的模式转变.
- 目前的治疗包括针对驱动突变,细胞增殖途径和免疫检查点的药物.
- 研究正在迅速推进新发现和组合策略.
研究的目的:
- 审查针对高级非小细胞肺癌的针对性治疗的最新进展.
- 专注于针对性治疗的临床试验数据.
- 突出了解抵抗机制的进展.
主要方法:
- 发表的临床试验的审查.
- 对肺癌向治疗的数据进行分析.
- 预测生物标志物和抵抗机制的研究.
主要成果:
- 在开发针对肺癌的药物方面取得了重大进展.
- 确定新的点和组合疗法.
- 增加对向治疗的耐药性的了解.
结论:
- 针对性疗法显著改善了肺癌的治疗.
- 持续的研究对于开发新疗法和克服耐药性至关重要.
- 临床试验数据指导着针对性肺癌治疗的发展.
更多相关视频
05:17Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
Modified-Release Drug Delivery Systems: Site-Targeted
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
